Cardax Inc (CDXI)
0.00
USD |
OTCM |
Jun 24, 16:00
Cardax Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 24, 2024 | 5.337M |
| June 21, 2024 | 5.337M |
| June 20, 2024 | 5.337M |
| June 18, 2024 | 5.337M |
| June 17, 2024 | 5.337M |
| June 14, 2024 | 5.337M |
| June 13, 2024 | 5.337M |
| June 12, 2024 | 5.337M |
| June 11, 2024 | 5.337M |
| June 10, 2024 | 5.337M |
| June 07, 2024 | 5.337M |
| June 06, 2024 | 5.337M |
| June 05, 2024 | 5.337M |
| June 04, 2024 | 5.337M |
| June 03, 2024 | 5.337M |
| May 31, 2024 | 5.337M |
| May 30, 2024 | 5.337M |
| May 29, 2024 | 5.337M |
| May 28, 2024 | 5.337M |
| May 24, 2024 | 5.337M |
| May 23, 2024 | 5.337M |
| May 22, 2024 | 5.337M |
| May 21, 2024 | 5.337M |
| May 20, 2024 | 5.337M |
| May 17, 2024 | 5.337M |
| Date | Value |
|---|---|
| May 16, 2024 | 5.337M |
| May 15, 2024 | 5.337M |
| May 14, 2024 | 5.337M |
| May 13, 2024 | 5.337M |
| May 10, 2024 | 5.337M |
| May 09, 2024 | 5.337M |
| May 08, 2024 | 5.337M |
| May 07, 2024 | 5.337M |
| May 06, 2024 | 5.337M |
| May 03, 2024 | 5.337M |
| May 02, 2024 | 5.337M |
| May 01, 2024 | 5.337M |
| April 30, 2024 | 5.337M |
| April 29, 2024 | 5.337M |
| April 26, 2024 | 5.337M |
| April 25, 2024 | 5.337M |
| April 24, 2024 | 5.337M |
| April 23, 2024 | 5.337M |
| April 22, 2024 | 5.337M |
| April 19, 2024 | 5.337M |
| April 18, 2024 | 5.337M |
| April 17, 2024 | 5.337M |
| April 16, 2024 | 5.337M |
| April 15, 2024 | 5.337M |
| April 12, 2024 | 5.337M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.400M
Minimum
Jun 25 2020
21.33M
Maximum
Jul 11 2019
6.839M
Average
5.738M
Median
Jan 03 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.982M |
| Palatin Technologies Inc | 19.35M |
| iBio Inc | 26.41M |
| Theriva Biologics Inc | -11.08M |
| Oragenics Inc | 5.495M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.382M |
| Revenue (Quarterly) | 0.1046M |
| Total Expenses (Quarterly) | 0.8759M |
| EPS Diluted (Quarterly) | -1.74 |